London, UK – 25th August 2021 - The Citeline Awards finalists have been announced prior to the Awards ceremony taking place in Boston, USA, in October 2021.
Now in its 6th year, the Citeline Awards recognize a myriad of accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its highest achievers. There are 14 categories, covering a spectrum of key R&D activities, from successes in early and late-stage research, to advances in technological tools, to innovations in trial design and execution.
View the full list of 2021 Citeline Awards shortlist and categories here.
Karen Currie, Executive Director, Editorial, Citeline: “We’re delighted to announce The Citeline Awards finalists for 2021. From innovative new treatments to mitigate the impact of the coronavirus pandemic, to drug development programs making the largest potential influence in the rare disease space, the Awards showcase the critical role clinical R&D has played over the past year.”
Previously known as the CARE Awards, the Citeline Awards were established to recognize the outstanding contributors in the advancement of quality global healthcare, specifically within the development of new and needed medicines to market.
This year’s entries were rigorously reviewed by an independent panel of judges, representing all the core sectors of the R&D industry, and chosen for their depth of knowledge. The winners will be revealed at a ceremony in Boston, USA, on October 14.
“We’ve been astounded by the volume and high level of entries for the annual Citeline Awards. A huge congratulations to all those who’ve been shortlisted, it’s an incredible achievement. It’s been both a challenging and remarkable time for the industry. We’re delighted to recognize and reward those who’ve persevered and demonstrated outstanding contribution to clinical research and development.’ said Karen Currie.
About Informa Pharma Intelligence
Trusted by over 3,000 of the world’s leading pharmaceutical companies, CROs, medtech and biotech organizations, and healthcare service providers, the Pharma Intelligence suite of intelligence solutions delivers vital, accurate, and timely intelligence about the drug development pipeline to pharmaceutical and biomedical decision makers around the world.
At Pharma Intelligence, global teams of subject area experts follow and analyze key diseases, clinical trials, drug approvals and R&D activities as part of the breadth and depth of data available to customers.
For more information visit pharmaintelligence.informa.com.
Citeline, part of Informa’s Pharma Intelligence vertical, is the world’s most comprehensive source of real-time R&D intelligence for the pharmaceutical industry, featuring an unmatched intelligence collection and enrichment of global clinical trials, clinical trial investigator profiles and drug development pipelines. Citeline is the R&D Intelligence arm of Informa’s Pharma Intelligence vertical, one of the world’s leading providers of drug, device, company, clinical trial and market intelligence in the pharma and medtech markets.